Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC AGI-41998 | 2377492-26-5 | 99.94% | C22H16BrF3N4O2 | 50 MG
SDP

Catalog No. 5000355212
Encompass_Preferred

AGI-41998 is a potent and orally active inhibitor of methionine adenosyltransferase 2A (MAT2A) that effectively penetrates the blood-brain barrier. It shows inhibitory activities against MAT2A and S-adenosyl methionine (SAM) in HCT-116 MTAP-null cells with IC50s of 22 nM and 34 nM respectively. AGI-41998 significantly inhibits the proliferation of HCT-116 cells and tumor growth, and can be used to study the role of SAM regulation in the central nervous system (CNS) and colon cancer.

  • Potent and orally active inhibitor of MAT2A
  • Effectively penetrates the blood-brain barrier
  • Exhibits inhibitory activities against MAT2A and SAM in HCT-116 MTAP-null cells
  • Significantly inhibits proliferation of HCT-116 cells and tumor growth
  • Can be used for research on SAM regulation in the CNS and colon cancer

Catalog No. 50-003-55212 Supplier Medchemexpress LLC Supplier No. HY14577850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AGI-41998 is a potent and orally active inhibitor of methionine adenosyltransferase 2A (MAT2A) that effectively penetrates the blood-brain barrier. It shows inhibitory activities against MAT2A and S-adenosyl methionine (SAM) in HCT-116 MTAP-null cells with IC50s of 22 nM and 34 nM respectively. AGI-41998 significantly inhibits the proliferation of HCT-116 cells and tumor growth, and can be used to study the role of SAM regulation in the central nervous system (CNS) and colon cancer.

  • Potent and orally active inhibitor of MAT2A
  • Effectively penetrates the blood-brain barrier
  • Exhibits inhibitory activities against MAT2A and SAM in HCT-116 MTAP-null cells
  • Significantly inhibits proliferation of HCT-116 cells and tumor growth
  • Can be used for research on SAM regulation in the CNS and colon cancer

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.